6505--Famciclovir Tablets
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The VA National Acquisition Center intends to issue an unrestricted Request for Proposal (RFP) 36E79726R0017 for Famciclovir Tablets. This procurement aims to secure an uninterrupted source of supply for the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The solicitation is expected on or about March 23, 2026, with a tentative closing date of April 7, 2026.
Scope of Work
This procurement is for Famciclovir Tablets in specific dosages and package sizes:
- Famciclovir 125mg Tablets: 30 tablets per bottle, estimated annual usage of 1,012 bottles.
- Famciclovir 250mg Tablets: 30 tablets per bottle, estimated annual usage of 10,522 bottles.
- Famciclovir 500mg Tablets: 30 tablets per bottle, estimated annual usage of 13,642 bottles.
Contract & Timeline
- Type: Pre-Solicitation for an unrestricted procurement (RFP 36E79726R0017).
- Duration: One base year plus four pre-priced one-year option periods.
- Set-Aside: Unrestricted.
- Solicitation Release: On or about March 23, 2026.
- Tentative Closing Date: April 7, 2026.
- Published Date: March 5, 2026.
- NAICS Code: 325412.
Key Requirements
Offerors must provide an uninterrupted source of supply. The successful offeror's label with its unique NDC number must be the only label on the product, and VA labels must be able to securely adhere on top of the contractor's label. Distribution will be through the VA's and DoD's respective Pharmaceutical Prime Vendor Programs.
Submission & Evaluation
The solicitation will be issued electronically in commercial item format in accordance with FAR Part 12. All responsible sources may submit a timely offer. Interested offerors are advised to continuously check SAM.gov for any changes or amendments.
Point of Contact
Richard Mahario, Contract Specialist, can be reached at Richard.Mahario@va.gov or 708-786-5247.